Introduction
Babesiosis is a tick-borne malaria-like disease caused by intraerythrocytic protozoan Babesia, most commonly B. microti. The presentation is gradual on onset and varies among the species. We report a case of severe symptomatic Babesiosis co-infection with Lyme disease.
Case presentation
A 70-year-old male with known history of controlled hypertension, presented to the emergency department with sudden onset of headaches, high fevers, non-bilious vomiting and low urine output for the past 4 days. The patient had recently emigrated from Bangladesh 6 months ago and had been staying with his daughter in Eastern Long Island, NY. On admission, the patient found to have hemolytic anemia, thrombocytopenia and acute kidney injury.
Significant labs include hemoglobin of 10. The patient was started on a 7-day treatment with doxycycline and quinine to cover either infection. Later on, PCR test for B. microtii came back positive. He showed improvement in both symptoms and laboratory findings.
On the day of planned discharge, the patient began to complain of right-sided numbness and difficulty closing the mouth and right eye. The diagnosis of Bell palsy had been established. Borrelia burgdorferi serology then sent and it turned out to be positive. Doxycycline had been restarted for another 2 weeks and the patient was symptoms-free after the new course.
Discussion
Humans are opportunistic hosts to Babesia when bitten by nymph or adult ticks; the most known ticks are Ixodes. Babesiosis should be considered in patients who have a malaria-like illness in areas endemic for Babesia infection like the northeastern coastal region of USA.
The symptoms usually begin 2-4 weeks after a tick bite. The presentation includes constitutional symptoms, abdominal pain and dark urine. Patients may not recall any tick bites but most often there is a history of outdoor activity or travel to an endemic area. Labs finding include hemolytic anemia and elevated liver enzymes. Urinalysis reveals hemoglobinuria without red blood cells.
The diagnosis of Babesiosis is usually established by microscopic examination of Giems or Wright-stained blood smears, indirect immunofluorescent antibody tests and PCR.
In healthy individuals with intact spleens, the symptoms resolve spontaneously without treatment. For mild to moderate babesiosis, combination therapy with atovaquone and azithromycin for 7 days is most commonly recommended. However, in patients who are asplenic or immunocompromized, babesiosis is quite severe and is associated with higher mortality, 1 the preferred treatment is intravenous clindamycin and oral quinine, again for 7-10 days. In patients who are refractory to pharmacological treatment, red blood cells exchange transfusion has been shown to improve mortality. It is very important to consider other tick-borne agents that may be co-transmitted with Babesia such as B. burgdorferi; the agent of Lyme disease. 3 Similar geographic distribution and common vectors are likely responsible for this occurrence. Co-infection should be considered in patients with a poor response to conventional antimicrobial therapy or atypical clinical presentations.
An epidemiologic study of 136 babesiosis cases showed that 23% had coinfected with Borrelia on the basis of clinical and serologic findings. 4 Two separate studies showed that 10% of patients with Lyme disease had co-infection with B. microti based on serologic and PCR test results. 3, 5 When co-infection is suspected, as in our patient, physicians should consider treating Lyme disease empirically for 2-3 weeks.
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